A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Related studies linked through entity extraction aliases.